Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, discusses the importance of working with physicians to make sure they're comfortable prescribing biosimilars.
Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, discusses the importance of working with physicians to make sure they're comfortable prescribing biosimilars.
Transcript
How important is it to collaborate with physicians to make sure they are comfortable prescribing biosimilars and alleviate some of the concerns they might have?
There’s still an educational gap, I think, about biosimilars. It’s still a very new product on the oncology market. We have to understand that biologics are inherently complicated to make, so we have to be comfortable about them being made the same way regardless of who is manufacturing them. We are comfortable with the current therapeutics that are out there.
There will be more coming. How exactly we do it operationally is a challenge, whether we’re changing patients, new starts, each of these drugs is a different drug so we have to have a care plan or a regimen plan that includes those. So, there’s some operational characteristics that have to be worked out, and we’re working through those at OneOncology practices.
For the physicians, there’s still an educational component, and for the patients. Although really, patients have been very comfortable with making a therapeutic switch when their doctor explains to them that they’re getting a drug that’s just like the other drug. It’s not a generic but it’s analogous to a generic. Generics are only for small molecules. Biosimilars are for biologics, and they’re slightly different.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen